|
| Issue Date | Title | Author(s) |
| 29-Dec-2020 | A potential immunological diagnostic marker for acute myeloid leukemia: the expression of the immune checkpoint B and T lymphocyte attenuator | Radwan, Sara ; Kamal, Amany ; Nabih, N.A.; Elkholy, Amal ; Elleboudy, Nooran |
| 2021 | Circulating miRNA 20a, miRNA 140-5p and VEGF as Predictive Biomarkers of Metastasis in Liquid Biopsy of Breast Cancer Patients | AbdelHamid, Sherihan ; AbdelAziz, Hany; Kamal, Amany |
| Apr-2021 | Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome | Kamal, Amany ; Nabih, Nermeen A; Elleboudy, Nooran S; Radwan, Sara |
| 1-Dec-2011 | Expression of inhibitor of apoptosis protein (IAP) livin/BIRC7 in acute leukemia in adults: Correlation with prognostic factors and outcome | El-Mesallamy, Hala O.; Hegab, Hany M.; Kamal, Amany |
| 25-Nov-2016 | Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study | Kamal, Amany ; El-Hefny, Nadia H.; Hegab, Hany M.; El-Mesallamy, Hala O. |
| 1-Jul-2021 | Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes | Kamal, Amany ; Wasfey, Eman F; Elghamry, Wesam R; Sabry, Omar M; Elghobary, Hany A; Sara Mostafa Radwan |
| 1-Jul-2020 | The immune checkpoints Cytotoxic T lymphocyte antigen-4 and Lymphocyte activation gene-3 expression is up-regulated in acute myeloid leukemia | Radwan, Sara ; Elleboudy, Nooran S.; Nabih, Nermeen A.; Kamal, Amany |
| 2021 | Mixed Lineage Kinase Domain-Like Pseudokinase (MLKL) Gene Expression in Human Atherosclerosis with and without Type 2 Diabetes Mellitus | Kamal, Amany ; Sebak, Samer Ahmed; Sanad, Eman F. |
| 2021 | Serum MicroRNA-96 As a Potential Diagnostic Marker in Breast Cancer | AbdelHamid, Sherihan ; AbdelAziz, Hany; Kamal, Amany |
